FDVLX | VMVAX | FDVLX / VMVAX | |
Total Expense Ratio | 0.81 | 0.07 | 1,157% |
Annual Report Gross Expense Ratio | 0.81 | 0.07 | 1,157% |
Fund Existence | 47 years | 14 years | - |
Gain YTD | 7.132 | 6.882 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.47B | 32B | 26% |
Annual Yield % from dividends | 1.06 | 2.15 | 49% |
Returns for 1 year | -4.24 | 7.20 | -59% |
Returns for 3 years | 13.94 | 29.26 | 48% |
Returns for 5 years | 59.79 | 67.70 | 88% |
Returns for 10 years | 40.39 | 101.90 | 40% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VVPSX | 12.89 | 0.12 | +0.94% |
Vulcan Value Partners Small Cap | |||
FNFPX | 71.81 | 0.34 | +0.48% |
American Funds New Perspective 529-F-3 | |||
IVIPX | 30.80 | -0.06 | -0.19% |
VY® Invesco Equity and Income S2 | |||
FISEX | 34.65 | -0.08 | -0.23% |
Franklin Equity Income A | |||
QCERX | 21.68 | -0.05 | -0.23% |
AQR Large Cap Multi-Style R6 |